Oncology Building a Phase I oncology centre The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.
R&D Universities and pharma companies need each other to create ... Academics and pharma executives seemingly live in very different worlds.
News BioNTech sticks with cancer vaccine despite trial miss BioNTech's vaccine for head and neck cancer has failed a clinical trial, but it will wait for more data before deciding the programme's fate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
